Slate Bio
$4.8Mtotal raised · 2 rounds on record
$2.8Mlatest round · Venture round · Dec 2022 · 3 yr ago
1backers · Epidarex Capital
10+team · employees, estimated range
Overview
Advanced Treg Therapy for Autoimmune Diseases. For more information, contact [email protected].
Key facts
These are the key facts about Slate Bio on Alion as of Nov 13, 2026. Slate Bio is headquartered in Charlottesville, United States. It was founded in 2020. It has raised $4.8M in 2 funding rounds. The latest round is Venture - Series Unknown of $2.8M, announced in 2022.
- Headquarters
- Charlottesville, United StatesAlion company profile, updated Oct 13, 2026
- Founded
- 2020Alion company profile, updated Oct 13, 2026
- Employees
- 10+Alion company profile, an estimated range
- Total raised
- $4.8MSum of 2 equity rounds Alion knows
- Latest round
- Venture - Series Unknown · $2.8M · Dec 30, 2022SEC Form D filing · sec.gov
Official records
Funding and backers
Total raised
$4.8M
2 rounds on record
Latest round
$2.8M
Venture round · Dec 2022 · 3 yr ago
Team
11-50
employees, estimated range
Backers
1
Epidarex Capital
The money's age
Long since its last round
46 months since the last round · not hiring
Momentum
0/100
no fresh signals
Last sign of life
1 mo ago
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Dec 30, 2022
Raised a round Venture round $2.8M · SEC Form D
Dec 24, 2020
Raised a round Venture round $2M · SEC Form D
2020
Founded
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Dec 2022 | $2.8M | — | SEC Form D |
| Venture round | Dec 2020 | $2M | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | Slate Bio, Inc. | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Kurt WoerpelExecutive OfficerSEC Form D
Andrew KrouseExecutive Officer, DirectorSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Boomerang Medical is a bioelectronic medicine company targeting autoimmune diseases.
Unlocking Disease-Modifying Targets for Neurodegeneration. Learn more.
Ditto Bio discovers drugs for autoimmune diseases by harnessing parasite biology.
Shinobi Therapeutics is transforming cell therapy with scalable, immune-evasive iPSC-derived treatments for cancer and autoimmune diseases.
About Elpiscience is a clinical-stage biopharmaceutical company dedicated to the development of innovative immunotherapies for oncology and…
Oblenio Bio is pursuing broad immune reset as a transformative therapy for refractory autoimmune diseases through our LBL-051 T-cell…
People
Kurt Woerpel
Executive Officer
Andrew Krouse
Executive Officer, Director
Robert Creeden
Director
Kyparissia Sirinakis
Director
Brian Gallagher
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors
Epidarex CapitalVia a fund
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely
Shared investors
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Charlottesville
United States
HQ
10-50 est. staff
How to cite this page
Alion, "Slate Bio: key facts", as of Nov 13, 2026. https://alion.io/company/slatebio
These figures are published under a free licence. You may reuse them, including commercially, as long as you credit Alion and link back to this page. CC BY-SA 4.0